Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Næss, Sigrid ^a,b   Lie, Benedicte A ^a,c   Melum, Espen ^a   Olsson, Marita ^d   Hov, Johannes R ^a,b   Croucher, Peter J P ^e   Hampe, Jochen ^f   Thorsby, Erik ^a,b   Bergquist, Annika ^g   Traherne, James A ^h,i   Schrumpf, Erik ^a   Boberg, Kirsten Muri ^a,b   Schreiber, Stefan ^j   Franke, Andre ^j   Karlsen, Tom H ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j UNIVERSITY OF KIEL   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB3 ANTIGEN; NOTCH4 RECEPTOR; NOTCH RECEPTOR; NOTCH4 PROTEIN, HUMAN; ONCOPROTEIN;

ADOLESCENT; ADULT; AGED; ALLELE; ANCESTRY GROUP; ARTICLE; CHILD; CONDITIONAL LOGISTIC REGRESSION ANALYSIS; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; HAPLOTYPE; HLA A GENE; HLA B GENE; HLA C GENE; HLA DQB1 GENE; HLA DRB1 GENE; HLA DRB3 GENE; HLA TYPING; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIMARY SCLEROSING CHOLANGITIS; PROMOTER REGION; SCANDINAVIA; SCANDINAVIAN; SINGLE NUCLEOTIDE POLYMORPHISM; UNCONDITIONAL MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; CASE CONTROL STUDY; GENETICS; SCLEROSING CHOLANGITIS;

CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; HLA-B ANTIGENS; HLA-DRB1 CHAINS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; SCANDINAVIAN AND NORDIC COUNTRIES;

EID: 84929196931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114486     Document Type: Article

References (39)

1. Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing cholangitis. Lancet 382: 1587-1599.
2. Saarinen S, Olerup O, Broome U (2000) Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 95: 3195-3199.
3. Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, et al. (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 45: 670-675.
4. Trowsdale J, Knight JC (2013) Major Histocompatibility Complex Genomics and Human Disease. Annual review of genomics and human genetics.
5. Sollid LM, Jabri B (2013) Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol 13: 294-302.
6. Faraco J, Lin L, Kornum BR, Kenny EE, Trynka G, et al. (2013) Immuno Chip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 9: E1003270.
7. Howie B, Marchini J, Stephens M (2011) Genotype imputation with thousands of genomes. G3 1: 457- 470.
8. Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, et al. (2013) Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 8: E64683.
9. Dilthey A, Leslie S, Moutsianas L, Shen J, Cox C, et al. (2013) Multi-population classical HLA type imputation. PLoS computational biology 9: E1002877.
10. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, et al. (2007) Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450: 887-892.
11. Howson JM, Walker NM, Clayton D, Todd JA, Type 1 Diabetes Genetics C(2009) Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes, obesity & metabolism 11 Suppl 1: 31-45.
12. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, et al. (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44: 291-296.
13. International Multiple Sclerosis Genetics C, Wellcome Trust Case Control C, Sawcer S, Hellenthal G, Pirinen M, et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
14. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, et al. (1991) Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 13: 129-133.
15. Donaldson PT, Norris S (2002) Evaluation of the Role of MHC Class II Alleles, Haplotypes and Selected Amino Acid Sequences in Primary Sclerosing Cholangitis. Autoimmunity 35: 555-564.
16. Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, et al. (1999) HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53: 459-469.
17. Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, et al. (2007) Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens 69: 161- 169.
18. Hov JR, Kosmoliaptsis V, Traherne JA, Olsson M, Boberg KM, et al. (2011) Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology 53: 1967-1976.
19. Karlsen TH, Boberg KM, Olsson M, Sun J-Y, Senitzer D, et al. (2007) Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol 46: 899-906.
20. Wiencke K, Spurkland A, Schrumpf E, Boberg KM (2001) Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 34: 625-630.
21. Sayer DC, Whidborne R, De Santis D, Rozemuller EH, Christiansen FT, et al. (2004) A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3, 4, 5. Tissue Antigens 63: 412-423.
22. Sayer DC, Goodridge DM, Christiansen FT (2004) Assign 2.0: Software for the analysis of Phred quality values for quality control of HLA sequencing-based typing. Tissue Antigens 64: 556-565.
23. Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, et al. (2007) Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun 8: 275-278.
24. Tobler AR, Short S, Andersen MR, Paner TM, Briggs JC, et al. (2005) The SNPlex genotyping system: A flexible and scalable platform for SNP genotyping. Journal of biomolecular techniques: JBT 16: 398-406.
25. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genetic epidemiology 34: 816-834.
26. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44: 955-959.
27. Fuchsberger C, Abecasis GR, Hinds DA (2014) minimac2: faster genotype imputation. Bioinformatics.
28. Cordell HJ, Clayton DG (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes. Am J Hum Genet 70: 124-141.
29. Folseraas T, Melum E, Franke A, Karlsen TH (2011) Genetics in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 25: 713-726.
30. Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, et al. (2010) Genome-Wide Association Analysis in Primary Sclerosing Cholangitis. Gastroenterology 138: 1102-1111.
31. Melum E, Franke A, Schramm C, Weismuller TJ, Gotthardt DN, et al. (2011) Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 43: 17-19.
32. Yamane H, Paul WE (2013) Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev 252: 12-23.
33. Shayevitz C, Cohen OS, Faraone SV, Glatt SJ (2012) A re-review of the association between the NOTCH4 locus and schizophrenia. American journal of medical genetics Part B, Neuropsychiatric genetics: The official publication of the International Society of Psychiatric Genetics 159B: 477-483.
34. Valdes AM, Thomson G, Type 1 Diabetes Genetics C(2009) Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1. Diabetes, obesity & metabolism 11 Suppl 1: 46-52.
35. Rahman P, Elder JT (2012) Genetics of psoriasis and psoriatic arthritis: A report from the GRAPPA 2010 annual meeting. J Rheumatol 39: 431-433.
36. Bowlus CL, Li C-S, Karlsen TH, Lie BA, Selmi C (2010) Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: Unique clinical and human leukocyte antigen associations. Liver Transplantation 16: 1324-1330.
37. Zachary AA, Bias WB, Johnson A, Rose SM, Leffell MS (2001) Antigen, allele, and haplotype frequencies report of the ASHI minority antigens workshops: Part 1, African-Americans. Human immunology 62: 1127-1136.
38. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, et al. (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 74: 160-167.
39. Gabriel C, Furst D, Fae I, Wenda S, Zollikofer C, et al. (2014) HLA typing by next-generation sequencing - getting closer to reality. Tissue Antigens 83: 65-75.